Johnson Matthey leads FTSE after optimistic update, while AstraZeneca sees strength

Johnson Matthey leads FTSE after optimistic update, while AstraZeneca sees strength
Steve Goldstein
·2 min read

Shares of Johnson Matthey rose as much as 8% after the chemicals group and metals refiner said results would come in at the top end of expectations.